CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-11 | Lurker Nancy Director | Option exercise | +3,752 | 5,517 | ||
| 2025-04-11 | Lurker Nancy Director | Shares withheld for taxes | −901 | $27.00 | $24K | 4,616 |
| 2025-04-11 | Lurker Nancy Director | Option exercise · Restricted Stock Unit Award | −2,323 | 0 | ||
| 2025-04-11 | Lurker Nancy Director | Option exercise · Restricted Stock Unit Award | −3,752 | 7,503 | ||
| 2025-02-28 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale 10b5-1 | −1,938 | $34.00 | $66K | 7,717 |
| 2025-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise 10b5-1 | +2,746 | 10,463 | ||
| 2025-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes 10b5-1 | −808 | $34.80 | $28K | 9,655 |
| 2025-02-26 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award 10b5-1 | −2,746 | 8,240 | ||
| 2025-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +5,409 | 95,277 | ||
| 2025-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,402 | $34.80 | $84K | 92,875 |
| 2025-02-26 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −5,409 | 16,229 | ||
| 2025-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +8,322 | 205,063 | ||
| 2025-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,695 | $34.80 | $129K | 201,368 |
| 2025-02-26 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −8,322 | 24,967 | ||
| 2025-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +6,866 | 80,789 | ||
| 2025-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,049 | $34.80 | $106K | 77,740 |
| 2025-02-26 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −6,866 | 20,598 | ||
| 2025-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +6,866 | 207,304 | ||
| 2025-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,049 | $34.80 | $106K | 204,255 |
| 2025-02-26 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −6,866 | 20,598 |
Page 14 of 41 · 804 trades